Equity Research, Broker Reports, and media content on ImmuPharma plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ImmuPharma plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

ImmuPharma plc

Company Profile

  • Personnel:
  • Dimitri Dimitriou, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ImmuPharma plc. We currently have 83 research reports from 6 professional analysts.

Date Source Announcement
28Jun22 17:44 RNS Immupharma PLC - Admission of new ordinary shares of £0.01
28Jun22 11:42 RNS Immupharma PLC - Result of AGM
27Jun22 07:00 RNS Immupharma PLC - Update on Lupuzor
20Jun22 15:22 RNS Immupharma PLC - Holding(s) in Company
01Jun22 07:00 RNS Immupharma PLC - Notice of AGM & Annual Report & Accounts
25May22 07:00 RNS Immupharma PLC - Finals results for y/e 31 December 2021
04May22 07:00 RNS Immupharma PLC - UPDATE on LUPUZOR™ PROGRESS to PHASE 3 with AVION
  • Frequency of research reports

     

  • Research reports on

    ImmuPharma plc

  • Providers covering

    ImmuPharma plc